Ipsen: ISU Belfast meeting sponsorship criticised for overall impression of luxury venue and social programme (AUTH/2554/11/12)

📅 2012 | 🖉 Dr Anzal Qurbain
📊

Key facts

Case numberAUTH/2554/11/12
ComplainantAnonymous group of NHS health professionals (non-contactable)
CompanyIpsen (Ipsen Limited, UK operating company; Irish operating company involved)
MeetingIrish Society of Urology (ISU) annual meeting
Location / dateCulloden Estate and Spa, Holywood, Belfast (Northern Ireland), September 2012
Complaint themeAlleged excessive hospitality due to luxury venue and social/leisure emphasis (golf and gala dinner)
Applicable Code year2012
Clauses consideredClauses 2, 9.1, 19.1
RulingNo breach of Clauses 2 and 19.1; breach of Clause 9.1
SanctionsUndertaking received; additional sanctions not stated
Complaint received26 November 2012
Case completed12 February 2013
AppealNo appeal

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • An anonymous group of NHS health professionals complained about pharmaceutical company support for the Irish Society of Urology (ISU) annual meeting held in Belfast (Northern Ireland) in September 2012.
  • The meeting programme featured a luxury 5-star venue (Culloden Estate and Spa) with prominent non-scientific imagery and messaging emphasising the “social aspect”.
  • The programme included a conference dinner during the meeting, and listed golf and a gala dinner at Stormont after the scientific sessions ended.
  • Ipsen’s involvement: paid €1,850 for an exhibition stand (cost split between UK and Irish affiliates); did not sponsor delegates; sponsorship acknowledged on the back page of the programme.
  • Ipsen initially stated its representatives did not attend the conference dinner, but later confirmed two Irish affiliate representatives attended the meeting and the dinner.
  • The Panel considered that, because the meeting was held in Northern Ireland, the ABPI Code applied, and UK companies could be responsible for overseas affiliates’ activities when carried out in the UK or relating to UK health professionals.
⚖️

Outcome

  • Breach: Clause 9.1.
  • No breach: Clauses 2 and 19.1.
  • The Panel was concerned that Ipsen’s initial response incorrectly stated its representatives did not attend the conference dinner; it stated this was unacceptable because self-regulation relied on full and frank disclosure, but it decided to take no further action on that point.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training